German drugmaker BioNTech has announced its new production of an mRNA-based vaccine to prevent malaria, the longstanding disease that has affected millions of people in Africa and other parts of the world. The company, which developed America’s first authorized coronavirus vaccine with U.S. pharmaceutical company Pfizer, said clinical trials shots would begin by the end of 2022.…